Pinealon
What We've Seen in Practice, and What the Research Says
Pinealon is a very small peptide, just three amino acids long, that has become one of the tools we reach for when someone's sleep and daily rhythm are out of order. It belongs to a family of short "bioregulator" peptides first developed in Russia, and it is the one associated with the pineal gland, the small structure at the center of the brain that helps set the body's day-night clock.
We will tell you two things clearly on this page. The first is that our recent experience with Pinealon has been good, and we are glad to have it. The second is that the published human research behind it is thin and comes mostly from a single research group, so our enthusiasm rests more on what we have seen than on a deep stack of clinical trials. Both of those things are true at once, and we would rather you have the honest version.
.svg)
What we've seen in practice
Pinealon has become one of our favorite peptides for circadian support, and that is a recent development. Interest in it grew as it was discussed more widely, including on Andrew Huberman's podcast, and as we used it more, we kept liking what we saw. Dr. Koniver now uses it regularly for people whose circadian rhythm is disrupted, whether from shift work, travel, age, or simply poor sleep that has lost its rhythm.
What patients tend to report is straightforward: they sleep better, their sleep feels more restorative, and they wake up more refreshed. Dr. Koniver describes the last few months with it as a genuine success, and he is comfortable calling it a wonderful peptide and one of our favorites right now. Just as importantly, he finds it very safe and very well tolerated, which matters for something people take to help them sleep.
One honest note belongs here. Pinealon is named for the pineal gland, and the idea behind it is that it supports that gland and its melatonin rhythm. That is the rationale we and others use it on, and it fits what we observe. It is worth knowing, though, that the careful published science on this peptide is really about neuroprotection and gene signaling in cells and animals, not a demonstrated increase in melatonin. So we use it for sleep and rhythm because that is what we see it help with.
Pinealon at a glance
A three-amino-acid peptide (Glu-Asp-Arg), one of the short Russian "bioregulator" peptides, associated with the pineal gland and daily rhythm [1]
.svg)
Sleep quality, circadian rhythm support, and neuroprotection in aging [1]
.svg)
Preclinical (cell and animal) work from mainly one research group, plus our own clinical experience; no large independent human trials [1, 2]
.svg)
By injection, typically in the evening
.svg)
Glu-Asp-Arg, formula C15H26N6O8, about 418.4 g/mol; a fully defined tripeptide, not a proprietary or variable sequence [5]
Investigational; not FDA-approved; prohibited in sport by WADA
A recent favorite for circadian and sleep support, which Dr. Koniver finds very safe and well tolerated. See what we have seen in practice above
Pinealon is a defined tripeptide with a fixed formula and weight. Naming it plainly is part of taking it seriously.
Where Pinealon comes from
Pinealon is one of a set of short peptides developed by Professor Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology. Their idea, worked on over several decades, was that very short peptides could act as gentle "bioregulators," nudging specific tissues back toward more youthful function. Different peptides in the family were matched to different tissues. Pinealon is the one tied to the pineal gland, the brain's timekeeper.
If that lineage sounds familiar, it is because another member of the same family, Epitalon, is already in our directory. Pinealon and Epitalon share the same basic concept: a tiny peptide, given in short courses, aimed at supporting the systems that tend to drift with age. Pinealon's particular focus is the day-night rhythm and the sleep that depends on it.
Pinealon (Glu-Asp-Arg)
Epitalon (Ala-Glu-Asp-Gly)
How it works
The mechanism is better studied in cells and animals than settled in people, so we describe it as the proposed basis for what we observe.
.svg)
The published work on this peptide, and on Glu-Asp-Arg specifically, centers on the idea that it enters cells and interacts with DNA to influence which genes are expressed, the proposed route for its neuroprotective effects. [1, 4]
.svg)
In laboratory and animal models, particularly under stress like low oxygen, it has been reported to protect nerve cells, support serotonin signaling, and reduce markers of oxidative damage. [1, 2]
.svg)
The reason we use it is its association with the pineal gland and circadian timing. This is the rationale behind its use for sleep, and it lines up with what patients report, even though a direct effect on melatonin levels has not been formally demonstrated.
A genuine preclinical rationale, a single-group evidence base, and encouraging clinical experience [1, 2]
What the research shows
We want to be careful here, because the gap between the marketing and the evidence on Pinealon is wide, and closing that gap honestly is the point of this page. The credible published research on Pinealon is preclinical: cell-culture and animal studies, concentrated in the work of one research group in Russia and largely published in specialist gerontology journals. That work is real and internally consistent, and it is the reason the peptide is interesting. What it is not is a body of large, independent, human randomized trials, and no such trials exist that we could verify.
Cell and animal studies
A real body of work, mainly one group
Neuroprotection, serotonin signaling, gene-expression effects, antioxidant activity
Preclinical, one research lineage [1,2]
Human randomized trials
None we could verify
Not established in controlled human studies
No independent human trial evidence
Our clinical experience
Recent, growing use
Better sleep, more restorative rest, good tolerability
Clinical observation, not a trial
How strong is the evidence
Our own clinical experience (green) is the strongest Pinealon-specific signal; there is no verified human-trial tier.
Our experience has been reassuring. Dr. Koniver describes Pinealon as very safe and very well tolerated, which is a large part of why we like it for something as sensitive as sleep. The preclinical record is consistent with that, and no serious adverse effects have been reported in the available literature.
The honest limit is the same one that runs through this page: there is no rigorous human safety data, so our confidence comes from experience rather than formal trials. The most common thing people notice early on is a change in their dreams or sleep pattern as their rhythm shifts, which usually settles. We avoid it in pregnancy and breastfeeding because there is no data there, and we are cautious in anyone with significant psychiatric instability. As with everything we offer, it belongs under physician supervision.
Regulatory status
Regulatory information current as of 12 August 2026. This is a summary, not legal or medical advice, and status can change.
As a medicine,
worldwide
Not approved anywhere; an investigational compound.
United States
Not FDA-approved. Pinealon is an obscure research peptide available through compounding pharmacies, and it was not among the specific peptides named in the recent federal compounding actions. Verify its precise standing at the time of reading.
Sport (WADA)
PROHIBITED
Prohibited as a non-approved substance (S0), at all times, in and out of competition. Off-limits for any competitor. [6]
Everywhere else,
in general
Because it is unapproved, source quality and purity vary and cannot be assured.
Regulatory information current as of 12 August 2026. Verify status at publication.
Pinealon, answered plainly
A very small peptide, three amino acids long (Glu-Asp-Arg), from the family of short Russian bioregulator peptides. It is associated with the pineal gland and is used to support sleep and circadian rhythm [1].
Not in the sense of large independent trials. The credible evidence is preclinical, from mainly one research group, and some of the human studies cited elsewhere could not be verified in the literature. Our own use of it is recent and encouraging but is clinical experience, not proof.[1, 2]
Circadian rhythm disruption and sleep, to help people sleep more deeply and wake more refreshed. It has become one of our favorite peptides for this over the last several months.
In our experience it has been very safe and well tolerated. The main early effect people notice is a shift in dreams or sleep as their rhythm changes. We avoid it in pregnancy and breastfeeding for lack of data.
No. It is prohibited by WADA as a non-approved substance, at all times. The regulatory section above has the detail.[6]
Related in this directory
References
- Khavinson V, Linkova N, Kozhevnikova E, Trofimova S. EDR Peptide: Possible Mechanism of Gene Expression and Protein Synthesis Regulation Involved in the Pathogenesis of Alzheimer's Disease. Molecules. 2020;26(1):159. PMID 33396470.
- Khavinson VKh, Lin'kova NS, Tarnovskaya SI, et al. Short peptides stimulate serotonin expression in cells of brain cortex. Bull Exp Biol Med. 2014;157(1):77-80. PMID 24909721.
- Voicekhovskaya MA, Chalisova NI, Kontsevaya EA, Ryzhak GA. Effect of bioregulatory tripeptides on the culture of skin cells from young and old rats. Bull Exp Biol Med. 2012;152(3):357-9. PMID 22803085.
- Silanteva IA, Komolkin AV, Morozova EA, et al. Role of Mono- and Divalent Ions in Peptide Glu-Asp-Arg-DNA Interaction. J Phys Chem B. 2019;123(9):1896-1902. PMID 30762356.
- Molecular data: Pinealon (Glu-Asp-Arg), PubChem CID 10273502, formula C15H26N6O8, molecular weight 418.40 g/mol.
- World Anti-Doping Agency. The Prohibited List. Non-approved substances (S0) are prohibited at all times.
This page is for informational and educational purposes and does not constitute medical advice, diagnosis, or treatment. Pinealon is an investigational peptide that is not approved by the FDA or any national health authority for any use, its human evidence base is limited and preclinical, and it is prohibited in competitive sport. Statements describing how Dr. Koniver and the Koniver Wellness team use Pinealon reflect clinical experience and judgment, which is not the same as controlled clinical evidence. Nothing here is a substitute for consultation with a qualified healthcare provider. Peptide therapy at Koniver Wellness is provided under physician supervision after appropriate screening, and the availability of any given peptide depends on its regulatory and supply status.
INTERESTED IN PEPTIDES?
START WITH THE RIGHT QUESTIONS.
Understand what peptides can and cannot do, what the evidence actually says, and whether physician-guided peptide therapy makes sense for you.